Gilead Sciences Set to Announce Third Quarter 2025 Financial Results
October 9, 2025 - 19:37
FOSTER CITY, Calif., October 09, 2025—Gilead Sciences, Inc. has revealed plans to disclose its financial results for the third quarter of 2025 on Thursday, October 30, 2025, following the market's closure. This announcement is highly anticipated by investors and analysts alike as it will provide insights into the company's performance during the quarter.
At 4:30 p.m. Eastern Time on the same day, Gilead's management team will conduct a webcast to discuss the financial results in detail. This session will not only cover the numbers but also offer a broader business update, shedding light on the company's strategic initiatives and outlook for the future.
As Gilead continues to navigate the ever-evolving landscape of the biopharmaceutical industry, stakeholders are eager to learn how the company is positioning itself amid ongoing challenges and opportunities. The webcast is expected to attract significant attention from market participants seeking to understand the implications of Gilead's performance and future direction.
MORE NEWS
March 17, 2026 - 05:46
Virginia joins multi-state lawsuit against OneMain FinancialVirginia has officially joined a coalition of a dozen states in filing a lawsuit against OneMain Financial, a major consumer loan company. The legal action, announced by Attorney General Jay Jones,...
March 16, 2026 - 02:28
Barclays Lifts PT on EOG Resources (EOG) to $140 From $133In a recent move underscoring confidence in the energy sector, investment bank Barclays has increased its price target for EOG Resources, Inc. The firm lifted its target to $140 per share, up from...
March 15, 2026 - 05:53
Peak War Panic Predicted to Grip Markets Within WeeksA leading market strategist warns that global financial markets are likely to experience a peak period of war-induced panic within the next one to three weeks. This forecast comes as both the...
March 14, 2026 - 22:13
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price PerformanceThe valuation of Brazilian medical education leader Afya is under scrutiny following a period of mixed performance for its shares. While the stock experienced a modest single-day gain of...